Miguel Forte

918 total citations
20 papers, 490 citations indexed

About

Miguel Forte is a scholar working on Epidemiology, Infectious Diseases and Physiology. According to data from OpenAlex, Miguel Forte has authored 20 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Infectious Diseases and 6 papers in Physiology. Recurrent topics in Miguel Forte's work include Biomedical Ethics and Regulation (6 papers), Pluripotent Stem Cells Research (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Miguel Forte is often cited by papers focused on Biomedical Ethics and Regulation (6 papers), Pluripotent Stem Cells Research (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Miguel Forte collaborates with scholars based in Italy, United States and Spain. Miguel Forte's co-authors include Nathalie Clerget–Chossat, Arnaud Foussat, Jean–Frédéric Colombel, Valérie Brun, Xavier Hébuterne, Michel Ticchioni, Pierre Desreumaux, Nathalie Belmonte, Laurent Beaugerie and Yoram Bouhnik and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and AIDS.

In The Last Decade

Miguel Forte

20 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miguel Forte Italy	9	261	105	104	85	85	20	490
Andrea Siegel United States	11	329 1.3×	54 0.5×	167 1.6×	63 0.7×	30 0.4×	15	523
Joerg Krueger Canada	12	103 0.4×	77 0.7×	192 1.8×	75 0.9×	27 0.3×	59	463
Mauro Giacomelli Italy	11	241 0.9×	56 0.5×	54 0.5×	103 1.2×	94 1.1×	19	632
Dorothea Ogmore Tilley Ireland	7	313 1.2×	55 0.5×	30 0.3×	119 1.4×	33 0.4×	9	536
Gary Albert United States	8	171 0.7×	36 0.3×	75 0.7×	167 2.0×	43 0.5×	12	607
Egle Kvedaraite Sweden	9	389 1.5×	50 0.5×	149 1.4×	100 1.2×	53 0.6×	12	530
Kathrin Pieper Germany	5	329 1.3×	56 0.5×	72 0.7×	96 1.1×	23 0.3×	6	532
J. Gonzalo Ocejo‐Vinyals Spain	13	133 0.5×	43 0.4×	46 0.4×	62 0.7×	23 0.3×	52	379
Andrea Henden Australia	9	301 1.2×	42 0.4×	156 1.5×	128 1.5×	14 0.2×	24	540
Nina K. Steckel Germany	18	425 1.6×	59 0.6×	157 1.5×	124 1.5×	19 0.2×	36	970

Countries citing papers authored by Miguel Forte

Since Specialization

Citations

This map shows the geographic impact of Miguel Forte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Forte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Forte more than expected).

Fields of papers citing papers by Miguel Forte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miguel Forte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Forte. The network helps show where Miguel Forte may publish in the future.

Co-authorship network of co-authors of Miguel Forte

This figure shows the co-authorship network connecting the top 25 collaborators of Miguel Forte. A scholar is included among the top collaborators of Miguel Forte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel Forte. Miguel Forte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alsultan, Abdulrahman, Dominique Farge, Sven Kili, et al.. (2024). International Society for Cell and Gene Therapy Clinical Translation Committee recommendations on mesenchymal stromal cells in graft-versus-host disease: easy manufacturing is faced with standardizing and commercialization challenges. Cytotherapy. 26(10). 1132–1140. 5 indexed citations

Ikonomou, Laertis, Natividad Cuende, Miguel Forte, et al.. (2023). International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products. Cytotherapy. 25(9). 920–929. 13 indexed citations

Cuende, Natividad, Rachele Ciccocioppo, Miguel Forte, et al.. (2022). Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products. Cytotherapy. 24(7). 686–690. 30 indexed citations

Foussat, Arnaud, Sylvie Grégoire, Nathalie Clerget–Chossat, et al.. (2017). Regulatory T Cell Therapy for Uveitis: A New Promising Challenge. Journal of Ocular Pharmacology and Therapeutics. 33(4). 278–284. 13 indexed citations

Bauer, Gerhard, et al.. (2016). The path to successful commercialization of cell and gene therapies: empowering patient advocates. Cytotherapy. 19(2). 293–298. 14 indexed citations

Sánchez, F. Giménez, et al.. (2016). Impact of vaccination uptake on hospitalizations due to rotavirus acute gastroenteritis in 2 different socioeconomic areas of Spain. Human Vaccines & Immunotherapeutics. 12(4). 1035–1039. 6 indexed citations

Dominici, Massimo, et al.. (2016). Science, ethics and communication remain essential for the success of cell-based therapies. SHILAP Revista de lepidopterología. 2(3). 146–146. 4 indexed citations

Deans, Robert, Kurt C. Gunter, Massimo Dominici, & Miguel Forte. (2015). Part 5: Unproven cell therapies and the commercialization of cell-based products. Cytotherapy. 18(1). 138–142. 7 indexed citations

Cuende, Natividad, Christopher A. Bravery, Miguel Forte, et al.. (2014). The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns. Cytotherapy. 16(12). 1597–1600. 40 indexed citations

10.

Desreumaux, Pierre, Arnaud Foussat, Matthieu Allez, et al.. (2012). Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease. Gastroenterology. 143(5). 1207–1217.e2. 299 indexed citations

11.

Desreumaux, Pierre, Laurent Beaugerie, Yoram Bouhnik, et al.. (2011). Autologous Cellular Therapy Open Label Phase I Study in Crohn's Disease With Type 1 Regulatory (Tr1) Lymphocytes (CATS1). Gastroenterology. 140(5). S–589. 2 indexed citations

12.

Matos, Olga, Bettina Lundgren, Kamal Mansinho, et al.. (2000). Evaluation of two nested polymerase chain reactions for diagnosis of Pneumocystis carinii pneumonia in immunocompromised patients. Clinical Microbiology and Infection. 6(3). 149–151. 8 indexed citations

13.

Forte, Miguel, et al.. (1992). Cytolytic T-cell Activity Against Mycobacterial Antigens in HIV. AIDS. 6(4). 407–412. 13 indexed citations

14.

Forte, Miguel, Gary Maartens, Colin Stubberfield, et al.. (1992). T-lymphocyte responses to Pneumocystis carinii in healthy and HIV-positive individuals.. PubMed. 5(4). 409–16. 11 indexed citations

15.

Forte, Miguel, et al.. (1991). In-vitro interaction of human macrophages with Pneumocystis carinii.. PubMed. 72(5). 589–98. 8 indexed citations

16.

Forte, Miguel, et al.. (1990). [Tinea capitis in adults. Description of 3 cases].. PubMed. 125(1-2). 27–8. 1 indexed citations

17.

Antunes, Francisco, et al.. (1987). Malaria in Portugal 1977–1986. Transactions of the Royal Society of Tropical Medicine and Hygiene. 81(4). 561–562. 3 indexed citations

18.

Antunes, Francisco, et al.. (1987). Visceral leishmaniasis recrudescence in a patient with AIDS. Transactions of the Royal Society of Tropical Medicine and Hygiene. 81(4). 595–595. 11 indexed citations

19.

Puiatti, P, et al.. (1986). Ketoconazole treatment in superficial mycoses.. PubMed. 12(5). 405–7. 1 indexed citations

20.

Forte, Miguel, et al.. (1957). Prophylaxis of Scarlet Fever by Antibiotics.. 17. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact